Artigo Acesso aberto

Health Technology Assessment

2010; IEEE Engineering in Medicine and Biology Society; Volume: 29; Issue: 3 Linguagem: Inglês

10.1109/memb.2010.936553

ISSN

1937-4186

Autores

Giuseppe Turchetti, Enza Spadoni, Eliezer Geisler,

Tópico(s)

Pharmaceutical Economics and Policy

Resumo

This article describes health technology assessment (HTA) as an evaluation tool that applies systematic methods of inquiry to the generation and use of health technologies and new products. The focus of this article is on the contributions of HTA to the management of the new product development effort in the biomedical organization. Critical success factors (CSFs) are listed, and their role in assessing success is defined and explained. One of the conclusions of this article is that HTA is a powerful tool for managers in the biomedical sector, allowing them to better manage their innovation effort in their continuing struggle for competitiveness and survival.

Referência(s)